Skip to content

Accelerating therapeutic development with data-informed biotechnology

HPV_5j6r_pore
explore

OUR
MISSION

At Gattaca Therapeutics, we believe that effective therapeutics for treatment of diseases plaguing humanity today can be discovered at the intersection of disease biology, advanced computing with automated AI/ML approaches, and smart engineering.

With our experience and excellence in research combined with cutting-edge advances in biotechnology, we envision a therapeutic paradigm to help ease the burden of diseases in our society today.

Our data ingestion, knowledge graph and automated workflow analysis platform, together with expert bio-engineering, has the potential to bring novel breakthrough therapeutics to patients for faster, effective, and cost-efficient treatments.

WHAT WE DO

Slide Background

Drawing biologically relevant information from rapidly growing health data to create effective and safe therapeutics is recognised as a highly complex and time-consuming scientific challenge

comic
Slide Background

Our Pipeline

By prioritising in-silico therapeutic design in the context of the disease, our AI systems together with specialised domain expertise allow us to develop and test our therapeutics rapidly in clinical settings

Slide Background

Next-Gen Therapeutics

Our process merges data-driven medicine with effective gene therapy which can provide higher quality and safer outcomes for personalised treatment

comic

OUR FOCUS

Slide Background

Dermatological infections

Skin disorders caused by pathogens, especially viruses, represent a major bulk of the global skin disease incidence. The Human Papilloma Virus (HPV) and Herpes Simplex (HSV1/ HSV2) infect people at all stages of life, affecting over 4 billion people combined. Traditional medical interventions and current drugs used to treat warts and herpes have very low efficacies and do not prevent recurrence.

With our AI-guided approach, we are aiming to deliver a bioengineered therapeutic capable of eliminating viral infections in the skin with far better safety and accuracy.

Home

BHUSHAN BONDE

Co-Founder & CEO

A veteran of pharma R&D, Dr. Bonde has more than 15 years of experience in computational biology and bioinformatics. He holds a

Home

SANDESH CHOPADE

Co-Founder & COO 

After obtaining a B.Tech in Bioengineering from IIT Kanpur and a MSc in Genetics from UCL, Sandesh was immediately drawn to academic research. With over 5 years of experience as a bioinformatician, he is committed to our mission – to help further genetic healthcare for the benefit of people afflicted with common and rare disorders. He is currently affiliated as a research fellow in population genetics research at UCL.

NAMITA NARKHEDE

CMO

Dr. Namita holds a MD degree in Dermatology and Venerology, and has a keen interest in implementing cutting-edge therapeutics in the clinic. She is our in-house medical expert and tirelessly facilitates the real-world validation for our in-silico work.

Home

DNYANDEO CHOPADE

Scientific Advisor

With more than 26 years of experience as a leading medical geneticist in India, Dr. Chopade (MS Anatomy, PhD Medical Genetics) has been spearheading a mission to raise awareness and provide better genetic healthcare to every strata of our society. Our work at Gattaca TX continually benefits from his experience and expertise. 

Home

Contact Us

General

info@gattacatx.com

Partnerships 

partnerships@gattacatx.com

Investors 

investors@gattacatx.com

Careers 

careers@gattacatx.com

0